We bring deep expertise and passion to our work addressing numerous health challenges around the world. AbbVie is committed to addressing the world's recognized health challenges, including neglected tropical diseases (NTDs), infections that disproportionately impact the world's poor and marginalized populations. According to the World Health Organization, more than 1 billion people suffer from one or more of these conditions.
In 2014, more than 100 of AbbVie’s most experienced scientists contributed 13,500 hours of their expertise to helping solve NTDs through drug development projects, advisory boards and compound screening partner organizations. In addition, we provided a large library of diverse chemicals to screen against many NTDs, and our Executive Council on Neglected Diseases coordinates efforts across the company to contribute innovative technologies, compounds for screening, and our scientific expertise. We collaborate with the following partners: